This is a paid advertisement. See full disclaimer below.
| Dear profit seeker, We all have "that" friend… the one who insists he got a hole-in-one that time he went golfing alone – and nobody was there to see it. Yeah, right. I'll bet it happened the same day he caught a 20-foot marlin on a deep-sea fishing trip with Tiger Woods. Or the same day a supermodel slipped him her phone number in an elevator. I'm not one to believe in fish stories (or supermodel stories, for that matter)… So when I uncovered a biotech company that claimed to have "cured baldness" I thought, 'Oh sure, feed me another one…" I mean, are you kidding me? How could a biotech company that no one's ever heard of have discovered a cure that mankind has spent at least 5,000 years searching for? The company is called Biologix Hair Inc., and it's publicly traded on the OTC right now (symbol BLGX). My name's Ian Cooper, by the way, and like I said – I was going to dismiss Biologix… but then a funny thing happened. I saw the before-and-after photos myself, and I was intrigued. I couldn't help it. Turns out this technology is being used right now – and has been, safely, for the last 8 years – on 5,000 pre-clinical trial patients. The "before" photos show men who had just a little fuzz left on their shiny scalps, and women with huge gaping patches of white across the tops of their heads. And then the "afters"…you have to see them to believe it. Most, if not all, of the hair grew back naturally, thick and full, in the same color it always was. Then I got a look at the data for these 5,000 patients…and the success rate for men is an incredible 80%–85%. And it's 90% for women! I kept thinking, "There's just no WAY this could be true…but if it is, I'm looking at a potential goldmine…" So I started digging. Now that could have been the end of the story if it wasn't for a curious piece of information…that led to another piece of information… and so on…and like breadcrumbs I followed each lead to see where it would go. And what I discovered about this patent-pending baldness cure transformed what (I thought) was a joke into my stock recommendation of the decade. That's why I'm writing you today – I believe it's a ground-floor opportunity that could turn your $10,000 into $80,960 in the next 12 to 18 months… all thanks to the company that's developed the first REAL cure for baldness. And I've been right about this kind of thing before. In fact, if you'd started following along with me 5 years ago, back in 2008 – you know, in the midst of the worst economic crisis this (or any) generation has ever seen – You could've turned $10,000 into a cool $2.2 MILLION. Again, that's no fish story. I've posted my track record right here for all to see. But I'm not here to brag. I'm here to give you full access to a special online report (FREE, by the way) I've just posted. I want to show you the incredible story I've uncovered, including all the proof I found that Biologix is the real thing. It details the Top 5 Reasons why this biotech stock could be the one that jump-starts your retirement… …with a pretty nice 809% potential profit. (Well, 809.6% to be exact.) For starters, you have to consider the size of their potential market – and the sheer number of people who are looking for a medical cure for hair loss that REALLY WORKS. Just in the United States alone there are 35 million men and 25 million women who today are suffering from hair loss. I'm one of them…maybe you are, too! As you'll soon see, Biologix has been contracting with leading medical doctors all over the world seeking to be first in line to obtain exclusive purchasing and treatment rights to the Biologix Hair Therapy System™. And that international network is lining up human patients waiting to try the procedure. So that's a total universe of more than 3.28 million people to-date—and that future revenue base is expanding… The therapy—up for possible FDA approval over the next 3 or more years—should have no problem tapping into the massive $3.5 billion U.S. hair loss market. Not to mention the rest of the world. And as you'll soon see, this is a globally focused biotech company. And while they work towards obtaining regulatory approvals, Biologix is launching a three-pronged campaign to ensure ongoing market success. Take a look:
On top of that, their management team is one of the best and most experienced I've ever evaluated. PLUS, they have a medical advisory team that's a virtual all-star line-up of world-class hair loss specialists. It's headed up by Beverly Hills surgeon Dr. Craig Ziering, who's known as "The Hair Restoration Surgeon to the Stars." (Again, no joke – look it up.) This barely scratches the surface of my Top 5 Reasons Biologix is a STRONG buy – the rest is all in my special online report, which you can read for free by clicking here. Just wait until you see #4 in my report…that's the one that made me want to move NOW on this stock. This factor alone could drive up the price 809.6%—which makes it imperative that you get in now for the biggest potential profits. Wait too long and the wave will pass you by. Okay, I'll just tell you now – Biologix is actively seeking listing on the NYSE Markets. When that happens, it will show up on Wall Street's radar but that's not all. The news is really a mixed bag. First, it reinforces the credibility of this stock. And second, it means that the uplisting will put Biologix in the international mainstream spotlight. The process is in motion. Biologix has secured the services of Akerman Senterfitt, a leading U.S.-based law firm with more than 550 lawyers waist-deep in extensive securities industry experience to get the uplisting to NYSE Markets. So, if you wait to act after the listing, you'll have missed the great leverage now offered by getting in front of this amazing opportunity. I believe Biologix is seriously undervalued…and all the research I've uncovered tells me it has the potential to turn every $10,000 invested into $80,960 in 12 to 18 months. That's a stunning 809.6% potential GAIN. Remember, this emerging biotech small-cap company has already been tested on over 5,000 people during pre-clinical trials over an 8-year period …with a 90% success rate of growing natural, full, real hair… proven safe…and no negative side effects! It's not a shampoo, scalp massager or spray-on hair. And it's NOT a dangerous surgery. It's a simple out-patient medical procedure based on 20+ years of research into hair loss. It uses an injectable drug formulation known as Biologix Revive™ which includes a nutritional package of essential vitamins and minerals as well as two highly researched pharmacological agents that work to reverse hair loss. You can find out more about how it works – and why it treats the TRUE cause of hair loss that so many other "hair loss" systems ignore – in my online special report. So let's review. Biologix offers…
Pick up the phone and call your broker, or go online to buy your shares of Biologix Hair now (OTCBB: BLGX). Whatever you do, don't wait. The price won't stay this low for long. And you can check out my free special report online – click here to read it now. You'll also see exactly how I calculated my potential profit projections…and why I believe this stock could soar from $3.80 to $16.60 in 12 months…and up to $33.20 in 18 months. P.S. In the time it took me to write you this note, the stock price has already gone up a little since I made my projections from $3.80 a share. Don't wait. Buy your shares of Biologix Hair Inc (BLGX) now. You don't want to be stuck reminiscing about "the one that got away"! Disclaimer: Ian Cooper's Speed Retirement System is an independent circulation newsletter. This online report is a solicitation for subscriptions and a paid promotional advertisement of the featured Company. Market Authority, Inc. received an editorial fee of ten thousand dollars from Gruppen Investments, LTD. This company was chosen to be profiled after Ian Cooper's Speed Retirement System completed due diligence on the company. Market Authority and Ian Cooper's Speed Retirement System expect to generate subscriber revenue and new online newsletter subscribers, the amount of which is unknown at this time, resulting from the online distribution of this report. Gruppen Investments, LTD paid thirty thousand dollars to advertising agencies for the costs of creating this report online, in an effort to build investor awareness. This report does not provide an analysis of a company's financial position. The featured Company's financial position and all other information regarding the featured Company should be verified directly with the Company. Information about many publicly traded companies and other relevant information can be found at the Securities and Exchange Commission's website at www.sec.gov. The information contained herein contains forward-looking information within the meaning of section 27a of the Securities Act of l933, as amended, and section 21e of the Securities Exchange Act of l934, as amended, including statements regarding expected growth of the featured Company. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act, statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the Company's actual results of operations. It is recommended that any investment in any security should be made only after consulting with your investment advisor and only after reviewing all publicly available information, including the financial statements of the company. This online report is not intended to be, nor should it be construed as, an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation of the purchase of the featured Company's securities. The information in this online report is believed to be reliable, but its accuracy cannot be guaranteed. |
| This email is a paid advertisement. It is for a product or service that is not offered, recommended or endorsed by Trading in America and neither the company nor its affiliates bear responsibility or control over the content of the advertisement and the product or service offered. Proceed at your own risk. |
No comments:
Post a Comment